GlassScriptCds Broad Portfolio Offering
Payments companies reported to CMS as associated with Cds Broad Portfolio Offering. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Cds Broad Portfolio Offering, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Cds Broad Portfolio Offering
These are the largest totals companies reported as associated with Cds Broad Portfolio Offering. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Mohamad Mahayni | Muskogee, OK | Cardiovascular Disease | $272.91 |
| Laura Smith | Billings, MT | Family | $224.26 |
| Soni Zacharias | Oklahoma City, OK | Interventional Cardiology | $220.02 |
| Isma Javed | Shawnee, OK | Internal Medicine | $219.26 |
| James Campbell | Broken Arrow, OK | Family Medicine | $205.96 |
| Auroa Badin | Columbus, OH | Clinical Cardiac Electrophysiology | $196.61 |
| Brenda Wilson | Oklahoma City, OK | Family | $194.07 |
| Mark Richards | Pocatello, ID | Clinical Cardiac Electrophysiology | $190.17 |
| Ian Parker | Oklahoma City, OK | Clinical Cardiac Electrophysiology | $186.13 |
| Tomasz Swierkosz | Lawton, OK | Cardiovascular Disease | $172.18 |
Prescribed Cds Broad Portfolio Offering?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.